Navigation Links
Promising Parkinson's Disease Research Highlighted by The Michael J. Fox Foundation to Accelerate Drug Development
Date:7/11/2013

ased therapeutic potential as it targets both early amyloid assemblies as well as pre-existing aggregates.

Symptomatic Research

  • Cynapsus Therapeutics' development of APL-130277, a novel formulation of the drug apomorphine, as a rescue medication for intermittent OFF episodes in PD. APL-130277 is a thin film strip that dissolves under the tongue.
  • NeuroDerm's clinical research on continuous administration of levodopa and carbidopa through a "pump-patch." This technology could maintain continuous and constant concentration of levodopa in the blood, which should significantly decrease motor fluctuations and possibly reverse dyskinesia.

To date, the Foundation has funded $325 million in research, more than $84 million of which has been directed to over 185 unique projects led by industry partners.

For more information on the MJFF Partnering Program 1H 2013 participants and previously featured grantees, visit https://www.michaeljfox.org/research/opportunities-for-industry/partnering-program.html. The MJFF Research Partnerships team can be reached at ResearchPartnerships@michaeljfox.org.


'/>"/>
SOURCE The Michael J. Fox Foundation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Adult and Adolescent Vaccines Market to 2018 Report - Promising Novel Candidates in Late-Stage Development and Prevnar Approval for Use in Adults to Drive Growth
2. QIAGEN Expands Pipeline of Promising New Biomarkers for Development of Personalized Healthcare Companion Diagnostics
3. Novan Announces Promising Results of SB204 Clinical Study
4. International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma
5. Use Of Cryoablation For Treatment Of Breast Cancer Shows Promising Results
6. Statement from the Cystic Fibrosis Foundation on Promising Phase 2 Clinical Trial Results of Kalydeco and VX-661 (Vertex Pharmaceuticals Inc.)
7. University of Michigans Zell Lurie Institute Awards $112,000 to Promising Student Startups in 30th Annual Business Plan Competition and Dare to Dream Grant Program
8. Forbes Ranks SynCardia Among "Americas Most Promising Companies" for Second Straight Year
9. Meth Vaccine Shows Promising Results in Early Tests
10. Epigenetics R&D Pipeline - Histone Deacetylases (HDACs) Offer the Most Promising Targets and Outnumber Other Classes of Epigenetic Targets
11. Boston Scientific Announces Promising Clinical Data on New Products at the International Spine Intervention Society 20th Annual Scientific Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... N.J. , Dec. 17, 2014  IGI Laboratories, ... today the closing of its offering of $125 million ... 2019 (the "Notes").  The Notes were offered and sold ... under the Securities Act of 1933, as amended (the ... a fixed rate of 3.75% per year, payable semiannually ...
(Date:12/15/2014)... , December 15, 2014 ... Am 19. und 20. Februar sind ... Aegate SAFE MEDICINE ECOSYSTEM PARTNER PROGRAMM ™ ... zu besuchen. Diese Tagung soll ... die Möglichkeit geben, die neue profitablen Unternehmensdienstleistungen, ...
(Date:12/15/2014)... 12, 2014 Research and Markets ... http://www.researchandmarkets.com/research/ms3j8c/cardiac ) has announced the addition of the ...  report to their offering. Global Guidewires sector is ... North America accounts for nearly 35% ... claims approximately 25% (2018). Asia-Pacific ...
Breaking Medicine Technology:IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 2IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 4Symposium über Aegates Ecosystem-Partner-Programm für sichere Medikamente vom 19. - 20. Februar 2015 in Amsterdam 2Cardiac Guidewires - Global Trends, Estimates and Forecasts, 2012-2018 2Cardiac Guidewires - Global Trends, Estimates and Forecasts, 2012-2018 3Cardiac Guidewires - Global Trends, Estimates and Forecasts, 2012-2018 4
... , CLEVELAND , Feb. 9 DATATRAK International, ... eClinical solutions for the clinical trials industry, today announced that it ... seminar in Tel Aviv, Israel , focusing on eClinical solutions ... will identify and decipher the challenges, costs and obstacles customarily encountered ...
... , Feb. 9 Visage Imaging®, Inc., a wholly ... John Danahy joins as General Manager North America , ... industry, Johns brings a wealth of experience to the Visage team. ... managed the national sales organization and developed new business opportunities in ...
Cached Medicine Technology:DATATRAK International and PFC Pharma Focus to Co-Sponsor eClinical Solutions Seminar in Tel Aviv 2DATATRAK International and PFC Pharma Focus to Co-Sponsor eClinical Solutions Seminar in Tel Aviv 3DATATRAK International and PFC Pharma Focus to Co-Sponsor eClinical Solutions Seminar in Tel Aviv 4Visage Imaging Names John Danahy as General Manager North America, Sales and Services 2
(Date:12/19/2014)... December 19, 2014 This is a ... the global Gliquidone industry with a focus on the ... market status of the Gliquidone manufacturers and is a ... individuals interested in the industry. , Firstly, the report ... definition, applications and manufacturing technology. Then, the report explores ...
(Date:12/19/2014)... 19, 2014 The Hermitage Club ... in Southern Vermont’s Deerfield Valley, announced today that it ... classic rock songs. , Three time Grammy Award ... private concert followed by a trail naming ceremony. Hermitage ... names include: “I’m Alright” the theme song for the ...
(Date:12/19/2014)... 2014 (HealthDay News) -- A new study suggests a ... severe hot flashes and night sweats -- and higher ... flashes are common during menopause, affecting about 60 percent ... women after menopause, since they then face a higher ... suggest women who exhibit moderate or severe menopausal symptoms ...
(Date:12/19/2014)... Amy Norton HealthDay Reporter ... born to moms who were exposed to high levels of ... of developing autism, a U.S. study suggests. Researchers found ... 1990 and 2002, those exposed to the most air pollution ... who later developed autism. And exposure during the third trimester, ...
(Date:12/19/2014)... through the same U.S. airport gate, one infected passenger ... four-hour time span, illustrating just how easily the virus ... in this report were not prolonged and occurred in ... fact that measles is highly contagious," wrote a team ... the U.S. Centers for Disease Control and Prevention. ...
Breaking Medicine News(10 mins):Health News:Gliquidone Industry Global and China Analysis for 2019, Now Available at ReportsnReports.com 2Health News:Gliquidone Industry Global and China Analysis for 2019, Now Available at ReportsnReports.com 3Health News:Gliquidone Industry Global and China Analysis for 2019, Now Available at ReportsnReports.com 4Health News:Gliquidone Industry Global and China Analysis for 2019, Now Available at ReportsnReports.com 5Health News:Gliquidone Industry Global and China Analysis for 2019, Now Available at ReportsnReports.com 6Health News:The Hermitage Club Officially Names Four Ski Trails after Iconic Rock Songs by Grammy Award Winner Kenny Loggins 2Health News:Severe Hot Flashes During Menopause May Raise Hip Fracture Risk Later: Study 2Health News:Smog Exposure During Pregnancy Linked to Autism Risk 2Health News:Smog Exposure During Pregnancy Linked to Autism Risk 3Health News:Arriving Now at Gate 42: Measles 2Health News:Arriving Now at Gate 42: Measles 3
... has received FDA Clearance for their DPL™ Therapy System for temporary ... ... 16, 2008 -- LED Technologies, LLC announced today that the U.S. ... the relaxation of muscles and relief of muscle spasms, temporary relief ...
... moving, study finds , , FRIDAY, Nov. 14 (HealthDay News) - ... keep excess pounds at bay, according to a U.S. study. ... time, and shown that for children in densely population cities, ... Our new study of over 3,800 inner-city children revealed that ...
... breast cancer is driving a sub-type of the disease ... American women. , The pathway regulates how cells identify ... called proteasome targeting complexes. The work shows that basal ... making a new type of proteasome targeting complex. The ...
... Innovative approach could give heart attack victims, other patients ... News) -- U.S. government scientists say they have developed ... directly into the body to cool and to protect ... "ice slurry" can be pumped easily into the body ...
... finds nearly two-thirds of Americans believe so, even though ... 14 (HealthDay News) -- A majority of Americans, including many ... are at least partly to blame for their disease, ... nearly 1,500 American adults, researchers found 59 percent of ...
... innovative plan to get new life-saving drugs into the hands ... but can,t afford the massive costs will be unveiled to ... weeks. , "Pharmaceuticals have become an increasingly important part of ... of money spent on them in developed countries like Canada ...
Cached Medicine News:Health News:FDA Clears the DPL (Deep Penetrating Light) Therapy System for Over-the-Counter - Home Use 2Health News:Greener Neighborhoods Mean Slimmer Children 2Health News:UCLA scientists find cell pathway driving a deadly sub-type of breast cancer 2Health News:UCLA scientists find cell pathway driving a deadly sub-type of breast cancer 3Health News:IV 'Ice Slurry' Quickly Cools Body for Surgeries 2Health News:Lung Cancer Patients Get Blamed for Their Disease 2Health News:Lung Cancer Patients Get Blamed for Their Disease 3Health News:Affordable medicine plan goes global 2Health News:Affordable medicine plan goes global 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: